These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

203 related items for PubMed ID: 7167380

  • 1. [Monitoring and appraisal of the effects of blood transfusion and iron chelation in thalassemia major].
    Girot R, Triadou P, Bories D, Jeannel F, Thevenin M, Rymer JC.
    Nouv Rev Fr Hematol (1978); 1982; 24(5):281-7. PubMed ID: 7167380
    [Abstract] [Full Text] [Related]

  • 2. Intensive iron chelation therapy in beta-thalassemia major: some effects on iron metabolism and blood transfusion dependence.
    Silvestroni E, Bianco I, Graziani B, Lerone M, Valente M, Congedo P, Ponzini D, Costantini S.
    Acta Haematol; 1982; 68(2):115-23. PubMed ID: 6812366
    [Abstract] [Full Text] [Related]

  • 3. Incidence of ototoxicity in pediatric patients with transfusion-dependent thalassemia who are less well-chelated by mono- and combined therapy of iron chelating agents.
    Tanphaichitr A, Kusuwan T, Limviriyakul S, Atipas S, Pooliam J, Sangpraypan T, Tanphaichitr VS, Viprakasit V.
    Hemoglobin; 2014; 38(5):345-50. PubMed ID: 25051423
    [Abstract] [Full Text] [Related]

  • 4. Effect of age at the start of iron chelation therapy on gonadal function in beta-thalassemia major.
    Bronspiegel-Weintrob N, Olivieri NF, Tyler B, Andrews DF, Freedman MH, Holland FJ.
    N Engl J Med; 1990 Sep 13; 323(11):713-9. PubMed ID: 2388669
    [Abstract] [Full Text] [Related]

  • 5. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S, Pathare AV.
    Ann Hematol; 2006 May 13; 85(5):315-9. PubMed ID: 16450126
    [Abstract] [Full Text] [Related]

  • 6. [Chelating therapy in beta-thalassemia].
    Musumeci S, Romeo MA, Di Gregorio F, Schiliró G, Russo G.
    Pediatr Med Chir; 1982 May 13; 4(1-2):55-9. PubMed ID: 7111040
    [Abstract] [Full Text] [Related]

  • 7. [Program of hypertransfusion and chelation with desferrioxamine in 10 patients with thalassemia major].
    Albo C, Cabrera J, Dios A, Castro M, Ares C, Constenla I, López D.
    Sangre (Barc); 1995 Dec 13; 40(6):441-5. PubMed ID: 8850225
    [Abstract] [Full Text] [Related]

  • 8. Normalisation of total body iron load with very intensive combined chelation reverses cardiac and endocrine complications of thalassaemia major.
    Farmaki K, Tzoumari I, Pappa C, Chouliaras G, Berdoukas V.
    Br J Haematol; 2010 Feb 13; 148(3):466-75. PubMed ID: 19912219
    [Abstract] [Full Text] [Related]

  • 9. Low serum ferritin levels are misleading for detecting cardiac iron overload and increase the risk of cardiomyopathy in thalassemia patients. The importance of cardiac iron overload monitoring using magnetic resonance imaging T2 and T2*.
    Kolnagou A, Economides C, Eracleous E, Kontoghiorghes GJ.
    Hemoglobin; 2006 Feb 13; 30(2):219-27. PubMed ID: 16798647
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Iron overload and desferrioxamine chelation therapy in beta-thalassemia intermedia.
    Cossu P, Toccafondi C, Vardeu F, Sanna G, Frau F, Lobrano R, Cornacchia G, Nucaro A, Bertolino F, Loi A, De Virgiliis S, Cao A.
    Eur J Pediatr; 1981 Nov 13; 137(3):267-71. PubMed ID: 7318837
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Iron chelation in thalassemia: combined or monotherapy? The Egyptian experience.
    El-Beshlawy A, Manz C, Naja M, Eltagui M, Tarabishi C, Youssry I, Sobh H, Hamdy M, Sharaf I, Mostafa A, Shaker O, Hoffbrand AV, Taher A.
    Ann Hematol; 2008 Jul 13; 87(7):545-50. PubMed ID: 18351337
    [Abstract] [Full Text] [Related]

  • 14. [Treatment of post-transfusion iron overload by deferoxamine].
    de Montalembert M, Llados A, Hannedouche T, Girot R.
    Arch Fr Pediatr; 1989 Feb 13; 46(2):99-105. PubMed ID: 2735804
    [Abstract] [Full Text] [Related]

  • 15. Chelation therapy in beta-thalassemia major. III. The role of splenectomy in achieving iron balance.
    Graziano JH, Piomelli S, Hilgartner M, Giardina P, Karpatkin M, Andrew M, LoIacono N, Seaman C.
    J Pediatr; 1981 Nov 13; 99(5):695-9. PubMed ID: 7299540
    [Abstract] [Full Text] [Related]

  • 16. Iron overload in thalassemia: comparative analysis of magnetic resonance imaging, serum ferritin and iron content of the liver.
    Mazza P, Giua R, De Marco S, Bonetti MG, Amurri B, Masi C, Lazzari G, Rizzo C, Cervellera M, Peluso A.
    Haematologica; 1995 Nov 13; 80(5):398-404. PubMed ID: 8566878
    [Abstract] [Full Text] [Related]

  • 17. [Treatment of iron overload due to repeated transfusions with subcutaneous infusions of desferrioxamine (author's transl)].
    Girot R, Thévenin M, Bouveret JP, Jeannel F, Rymer JC.
    Arch Fr Pediatr; 1980 Apr 13; 37(4):241-7. PubMed ID: 7406638
    [Abstract] [Full Text] [Related]

  • 18. Serum ferritin in children with thalassaemia regularly transfused.
    Letsky EA, Miller F, Worwood M, Flynn DM.
    J Clin Pathol; 1974 Aug 13; 27(8):652-5. PubMed ID: 4421996
    [Abstract] [Full Text] [Related]

  • 19. Delayed decrease in serum ferritin in polytransfused children with thalassemia major after continuous subcutaneous infusions of desferrioxamine.
    Schettini F, Mautone A, Cavallo L, Altomare M, Montagna O, Dell'Edera L.
    Acta Haematol; 1981 Aug 13; 66(2):96-101. PubMed ID: 6794319
    [Abstract] [Full Text] [Related]

  • 20. Serum ferritin level as a predictor of impaired growth and puberty in thalassemia major patients.
    Shalitin S, Carmi D, Weintrob N, Phillip M, Miskin H, Kornreich L, Zilber R, Yaniv I, Tamary H.
    Eur J Haematol; 2005 Feb 13; 74(2):93-100. PubMed ID: 15654898
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.